News

Deal Announcements

Collegium Pharmaceutical Collects $20 Million Series D

Wednesday, July 16, 2008 5:49:00 AM PDT | VentureDeal Staff
Cumberland, Rhode Island -- Collegium Pharmaceutical announced that it has received $20 million in its fourth round of venture capital funding.

The company is developing late stage pharmaceuticals that add clinical benefit to existing drugs that have already been proven safe and effective.

Frazier Healthcare Ventures led the round, which included Boston Millennia Partners and Westfield Capital Management.  

The company said that the proceeds from the financing will be used to continue development of its lead candidate, the "COL-003, a tamper resistant, abuse-deterrent, sustained release oxycodone formulation."

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1